Emergency Use Authorisation isn't the best pathway because approval is only valid for duration of emergency and may not allow for expansions of product. De Novo submission is likely still the only viable pathway, however I know for a fact that FDA is prioritising devices applicable to covid.
- Forums
- ASX - By Stock
- RAP
- Ann: Update on US FDA De Novo Classification Request
Ann: Update on US FDA De Novo Classification Request, page-316
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online